Showing results (1971-1980 of 2,138) with videos related to

Sort By:
Pageof 214
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trialJane F Apperley, Jorge E Cortes, Dong-Wook Kim, et al.
Clinical Breast Cancer|March 20, 2002
Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patientsS Jones, G Clark, S Koleszar, et al.
Leukemia|July 18, 2021
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202Amy S Ruppert, Allison M Booth, Wei Ding, et al.
Cancer Discovery|September 27, 2019
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11Xueting Lang, Michael D Green, Weimin Wang, et al.
Blood Cancer Journal|November 1, 2024
Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimenShai Shimony, Hari S Raman, Yael Flamand, et al.
Contact Dermatitis|August 27, 2024
Sensitisation to the acrylate co-polymers glyceryl acrylate/acrylic acid co-polymer, sodium polyacrylate and acrylates/C10-30 alkyl acrylate cross-polymer (Carbopol®) is rareLivia F Soriano, M M U Chowdhury, Philippa Cousen, et al.
Blood Advances|June 30, 2026
A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMMLAndrew M Brunner, Yiwen Liu, Jacqueline S Garcia, et al.
Molecular Genetics & Genomic Medicine|April 18, 2019
IgG4-related disease: Association with a rare gene variant expressed in cytotoxic T cellsJohn H Newman, Aaron Shaver, Jonathan H Sheehan, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2004
PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorderJing Chen, Daniel J Deangelo, Jeffery L Kutok, et al.
Cancer Cell|December 11, 2007
Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate allelesStefan Fröhling, Claudia Scholl, Ross L Levine, et al.
Pageof 214